These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31316785)

  • 1. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile.
    Gutin L; Piceno Y; Fadrosh D; Lynch K; Zydek M; Kassam Z; LaMere B; Terdiman J; Ma A; Somsouk M; Lynch S; El-Nachef N
    United European Gastroenterol J; 2019 Jul; 7(6):807-814. PubMed ID: 31316785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
    Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
    Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study.
    Selvig D; Piceno Y; Terdiman J; Zydek M; Umetsu SE; Balitzer D; Fadrosh D; Lynch K; Lamere B; Leith T; Kassam Z; Beck K; Lewin S; Ma A; Somsouk M; Lynch SV; El-Nachef N
    Dig Dis Sci; 2020 Apr; 65(4):1099-1106. PubMed ID: 31302808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
    Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Yang Z; Bu C; Yuan W; Shen Z; Quan Y; Wu S; Zhu C; Wang X
    Dig Dis Sci; 2020 Jan; 65(1):150-157. PubMed ID: 31367877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
    Allegretti JR; Kassam Z; Carrellas M; Mullish BH; Marchesi JR; Pechlivanis A; Smith M; Gerardin Y; Timberlake S; Pratt DS; Korzenik JR
    Am J Gastroenterol; 2019 Jul; 114(7):1071-1079. PubMed ID: 30730351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
    Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
    Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
    Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
    Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
    Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
    Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
    Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
    Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation in the treatment of Crohn disease.
    Collins M; DeWitt M
    JAAPA; 2020 Sep; 33(9):34-37. PubMed ID: 32841976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.